Foxp3 expression in human cancer cells
Open Access
- 22 April 2008
- journal article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 19
- https://doi.org/10.1186/1479-5876-6-19
Abstract
Transcription factor forkhead box protein 3 (Foxp3) specifically characterizes the thymically derived naturally occurring regulatory T cells (Tregs). Limited evidence indicates that it is also expressed, albeit to a lesser extent, in tissues other than thymus and spleen, while, very recently, it was shown that Foxp3 is expressed by pancreatic carcinoma. This study was scheduled to investigate whether expression of Foxp3 transcripts and mature protein occurs constitutively in various tumor types. Twenty five tumor cell lines of different tissue origins (lung cancer, colon cancer, breast cancer, melanoma, erythroid leukemia, acute T-cell leukemia) were studied. Detection of Foxp3 mRNA was performed using both conventional RT-PCR and quantitative real-time PCR while protein expression was assessed by immunocytochemistry and flow cytometry, using different antibody clones. Foxp3 mRNA as well as Foxp3 protein was detected in all tumor cell lines, albeit in variable levels, not related to the tissue of origin. This expression correlated with the expression levels of IL-10 and TGFb1. We offer evidence that Foxp3 expression, characterizes tumor cells of various tissue origins. The biological significance of these findings warrants further investigation in the context of tumor immune escape, and especially under the light of current anti-cancer efforts interfering with Foxp3 expression.Keywords
This publication has 27 references indexed in Scilit:
- Foxp3 Expression in Pancreatic Carcinoma Cells as a Novel Mechanism of Immune Evasion in CancerCancer Research, 2007
- Indoleamine 2,3-dioxygenase (IDO) expression in lung cancerCancer Biology & Therapy, 2007
- IL-2 and IL-15 Each Mediate De Novo Induction of FOXP3 Expression in Human Tumor Antigen-specific CD8 T CellsJournal of Immunotherapy, 2007
- ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISMAnnual Review of Pharmacology and Toxicology, 2005
- Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humansHuman Immunology, 2005
- Foxp3: a critical regulator of the development and function of regulatory T cellsMicrobes and Infection, 2004
- Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cellsJournal of Clinical Investigation, 2003
- Establishment of 15 Cancer Cell Lines From Patients With Lung Cancer and the Potential Tools for ImmunotherapyChest, 2002
- Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouseNature Genetics, 2001
- Selective growth in serum-free hormone-supplemented medium of tumor cells obtained by biopsy from patients with small cell carcinoma of the lung.Proceedings of the National Academy of Sciences, 1981